The percentage of STEMI patients that received DAPT (A), ACEI or ARB (B), beta blocker (C) and statin (D) during hospitalization in the first and second registry. * p < 0.05 compared with the first registry. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; DAPT, dual antiplatelet therapy; STEMI, ST segment elevation myocardial infarction.